EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 50 filers reported holding EVELO BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,446 | -80.3% | 7,990 | +75.1% | 0.00% | – |
| Q4 2022 | $7,348 | +47.0% | 4,564 | +74.7% | 0.00% | – |
| Q3 2022 | $5,000 | -93.4% | 2,612 | -79.3% | 0.00% | – |
| Q4 2021 | $76,000 | -50.0% | 12,588 | -41.6% | 0.00% | – |
| Q3 2021 | $152,000 | +334.3% | 21,538 | +745.0% | 0.00% | – |
| Q2 2021 | $35,000 | -7.9% | 2,549 | -27.4% | 0.00% | – |
| Q1 2021 | $38,000 | -28.3% | 3,512 | -19.8% | 0.00% | – |
| Q4 2020 | $53,000 | +783.3% | 4,380 | +262.0% | 0.00% | – |
| Q3 2020 | $6,000 | -73.9% | 1,210 | -74.3% | 0.00% | – |
| Q2 2020 | $23,000 | -23.3% | 4,712 | -41.4% | 0.00% | – |
| Q1 2020 | $30,000 | -56.5% | 8,043 | -52.9% | 0.00% | – |
| Q4 2019 | $69,000 | -13.8% | 17,070 | +30.7% | 0.00% | – |
| Q3 2019 | $80,000 | +142.4% | 13,058 | +256.3% | 0.00% | – |
| Q2 2019 | $33,000 | +1550.0% | 3,665 | +1859.9% | 0.00% | – |
| Q1 2019 | $2,000 | -97.6% | 187 | -97.2% | 0.00% | – |
| Q4 2018 | $85,000 | +226.9% | 6,567 | +208.6% | 0.00% | – |
| Q3 2018 | $26,000 | +271.4% | 2,128 | +238.9% | 0.00% | – |
| Q2 2018 | $7,000 | – | 628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 3,063,505 | $37,038,000 | 14.47% |
| Mayo Clinic | 484,953 | $5,863,000 | 7.05% |
| Flagship Pioneering Inc. | 22,900,069 | $276,862,000 | 5.04% |
| Trustees of Columbia University in the City of New York | 113,850 | $1,376,000 | 1.84% |
| Alphabet Inc. | 1,060,495 | $12,821,000 | 0.62% |
| Artal Group S.A. | 700,000 | $8,463,000 | 0.18% |
| Larson Financial Group LLC | 28,353 | $343,000 | 0.12% |
| PEDDOCK CAPITAL ADVISORS, LLC | 3,663 | $44,000 | 0.02% |
| CREDIT SUISSE AG/ | 2,705,511 | $32,710,000 | 0.02% |
| FMR LLC | 6,803,365 | $82,253,000 | 0.01% |